← Back to Search

Tissue Graft

Randomized for Atrial Fibrillation

Phase < 1
Waitlist Available
Led By Vikas Sharma, MD
Research Sponsored by University of Utah
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Patients undergoing primary elective CABG at the University of Utah Hospital
Ability to provided informed consent and follow-up with protocol procedures
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 month
Awards & highlights

Study Summary

This trial will compare the effects of hAM application and standard care on inflammation and atrial fibrillation after cardiac surgery.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 month
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 month for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Comparison of inflammatory response (systemic and pericardial) between patients who received hAM and controls
Comparison of the incidence of Post Op Atrial Fibrillation between patients who receive hAM and controls
Safety assessment of the use of human amniotic membrane during cardiac surgery by incidence of adverse events

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: RandomizedExperimental Treatment1 Intervention
Group II: ControlActive Control1 Intervention

Find a Location

Who is running the clinical trial?

University of UtahLead Sponsor
1,089 Previous Clinical Trials
1,728,345 Total Patients Enrolled
12 Trials studying Atrial Fibrillation
2,035 Patients Enrolled for Atrial Fibrillation
Vikas Sharma, MDPrincipal Investigator - University of Utah
University of Utah Hospital

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~7 spots leftby Mar 2025